Abstract
Machine learning and linear regression models using CGM and participant data reduced HbA1c estimation error by up to 26% compared to the GMI formula, and exhibit superior performance in estimating the median of HbA1c at the cohort level, potentially of value for remote clinical trials interrupted by COVID-19.
Keywords:
Continuous glucose monitoring; HbA1c estimation.
Copyright © 2021 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adolescent
-
Blood Glucose / analysis
-
Blood Glucose / metabolism
-
Blood Glucose Self-Monitoring / instrumentation
-
Blood Glucose Self-Monitoring / methods
-
Blood Specimen Collection / methods
-
Blood Specimen Collection / standards
-
Blood Specimen Collection / statistics & numerical data*
-
COVID-19 / epidemiology*
-
Child
-
Cohort Studies
-
Diabetes Mellitus, Type 1 / blood*
-
Diabetes Mellitus, Type 1 / epidemiology*
-
Female
-
Glycated Hemoglobin / analysis*
-
Glycated Hemoglobin / metabolism
-
Health Services Accessibility / statistics & numerical data
-
Humans
-
Machine Learning / standards
-
Male
-
Pandemics
-
Remote Sensing Technology / methods
-
Remote Sensing Technology / standards
-
SARS-CoV-2 / physiology
-
Statistics as Topic / instrumentation
-
Statistics as Topic / methods
-
Young Adult
Substances
-
Blood Glucose
-
Glycated Hemoglobin A